Treatment Approaches to Tardive Dyskinesia (16:24)

Listen in as Dr. Dawn Vanderhoef and Dr. Kaylee Mehlman, share their insights on therapeutic approaches to tardive dyskinesia, exploring its pathophysiology, its impact on the lives of patients, and management strategies for clinicians.

This podcast is sponsored and co-developed by Neurocrine Biosciences, Inc. This podcast is for educational purposes only and is not intended to promote any specific product. Both speakers are Neurocrine employees, and Dr. Kaylee Mehlman served as a paid consultant at the time of recording in February 2024. The content reflects Dr. Mehlman’s clinical judgment and personal experience.